{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/itch-in-pregnancy/management/itch-with-rash/","result":{"pageContext":{"chapter":{"id":"d71e492d-d64c-5494-84d9-05cd71b8bfe2","slug":"itch-with-rash","fullItemName":"Scenario: Itch with rash","depth":2,"htmlHeader":"<!-- begin field a784130a-0c3b-4898-a22b-872306a6b236 --><h2>Scenario: Management of itch with rash in pregnancy</h2><!-- end field a784130a-0c3b-4898-a22b-872306a6b236 -->","summary":"Covers the management of itch associated with rash (including pregnant-specific dermatoses such as polymorphic eruption of pregnancy, atopic eruption of pregnancy, and pemphigoid gestationis).","htmlStringContent":"<!-- begin item 45c707cb-6d6e-41e3-8ba8-b82fc3a023c4 --><!-- begin field 757c4a87-80e3-4c2b-b124-acbc015780ab --><p>From age 13 years onwards (Female).</p><!-- end field 757c4a87-80e3-4c2b-b124-acbc015780ab --><!-- end item 45c707cb-6d6e-41e3-8ba8-b82fc3a023c4 -->","topic":{"id":"830ea1e2-cb32-5c3f-9bff-b97f40f4fdca","topicId":"0ea3d4a3-2427-4849-bc55-80054c49c404","topicName":"Itch in pregnancy","slug":"itch-in-pregnancy","lastRevised":"Last revised in April 2020","chapters":[{"id":"cfb00c8c-6b8d-5313-9235-db3d54ef9fe2","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"eb121430-1a25-5f13-9fae-e0b66a6b9f12","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cb1d8e5a-761d-5459-b261-5a39bace8e7f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"43d69926-3fda-5446-98f6-e702b6f6a7bc","slug":"changes","fullItemName":"Changes"},{"id":"d38ab0ab-9d26-5e9c-8a65-c84f757478c4","slug":"update","fullItemName":"Update"}]},{"id":"51cdc19e-100c-53e7-b29f-5d685b193048","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8902a748-b146-5b57-abe1-091451c77944","slug":"goals","fullItemName":"Goals"},{"id":"a059b067-209f-59db-907b-726070df2908","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3e6e44dc-28c7-5241-93f5-7325020d69f0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6dd5be7f-5719-51e5-9ba3-4bd276d58393","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ff4b1619-d0fa-5a30-b016-f752dd1a58ec","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a9d890cc-f5a8-50dc-a480-972af8996451","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"da0e2154-9689-5cce-bf1c-6a631089e0db","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"62eeef76-fe68-5156-8085-03cdcbda803d","slug":"definition","fullItemName":"Definition"},{"id":"0c1f2380-13c7-59b1-99eb-5a7b0bea6df1","slug":"causes-of-itch","fullItemName":"Causes of itch"},{"id":"03c01225-fd1c-59bf-8dc6-05e6ed9e7571","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5c2186b4-396a-58cc-b5e6-89001f52feb2","slug":"complications","fullItemName":"Complications"},{"id":"6a1b05f7-a260-5843-8da6-4199a052e79c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c5cff2c3-a8d5-51b1-9c4f-e05a6c1e890e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7390b761-94e3-52ac-86d9-c4b8335b24da","slug":"causes-of-itch-without-rash","fullItemName":"Causes of itch without rash"},{"id":"318b78d3-8010-58d9-9a19-916fad7e9769","slug":"causes-of-itch-with-rash","fullItemName":"Causes of itch with rash"},{"id":"39a5a741-f8bd-57ac-bbdb-2afb0b87c766","slug":"itch-unrelated-to-pregnancy","fullItemName":"Itch unrelated to pregnancy"}]},{"id":"a6853d85-eed6-58d5-8861-02a8153e3a4b","fullItemName":"Management","slug":"management","subChapters":[{"id":"993d5c0f-c002-5409-8b0a-7185531987ec","slug":"itch-without-rash","fullItemName":"Scenario: Itch without rash"},{"id":"d71e492d-d64c-5494-84d9-05cd71b8bfe2","slug":"itch-with-rash","fullItemName":"Scenario: Itch with rash"}]},{"id":"e914c4d5-d732-56b3-9139-5073d0105c5d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"694b14b1-caab-5453-99fd-f87ffe47434c","slug":"emollients","fullItemName":"Emollients"},{"id":"9b27ac31-e5d0-5667-89cc-8fa7da893cbf","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"95ba7b87-a960-57fd-a754-512d887c1296","slug":"chlorphenamine","fullItemName":"Chlorphenamine"},{"id":"895255b5-5d22-52f0-803f-9c0934c95f35","slug":"promethazine","fullItemName":"Promethazine"}]},{"id":"570034fe-13c6-513c-8ce3-7c1e20f7eb49","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39893599-718c-523b-ace7-8b45f527372a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c92e06b1-1592-5069-91ce-9207ee694663","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3934dfd9-4d45-5afc-911c-e59b298c6799","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9f045912-2ce4-5a89-a031-2981e7057c12","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0bf093ec-c04a-57d7-966f-9bfa8d0117bd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"27b7fe79-30e3-5856-a8be-a7794359739c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3d4b2031-ea07-5c95-9f4e-2d40e8b37e40","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a6853d85-eed6-58d5-8861-02a8153e3a4b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"f4b34cdb-a051-5726-8339-f267b4c0b1ac","slug":"polymorphic-eruption-of-pregnancy","fullItemName":"Polymorphic eruption of pregnancy","depth":3,"htmlHeader":"<!-- begin field fda35015-e2d7-4ab7-ba5e-08d201896c78 --><h3>How should I manage suspected polymorphic eruption of pregnancy?</h3><!-- end field fda35015-e2d7-4ab7-ba5e-08d201896c78 -->","summary":null,"htmlStringContent":"<!-- begin item 0c96b684-5b8b-4d2a-9596-4007922d6f0b --><!-- begin field fe9d5b69-538a-49a8-af37-0d1ce4b37a4b --><ul><li><strong>Reassure the woman that although polymorphic eruption of pregnancy is unpleasant, it poses no serious risk to her or her baby.</strong><ul><li>Advise the woman that symptoms typically last 4–6 weeks, and usually resolve immediately following delivery (if they are still present at this time).</li></ul></li><li><strong>Provide <a class=\"topic-reference internal-reference\" href=\"/topics/itch-in-pregnancy/management/itch-with-rash/#self-care-advice\">self-care advice</a></strong> to relieve itching.</li><li><strong>Offer information and advice about polymorphic eruption of pregnancy.</strong> A patient information leaflet is available from the <a href=\"https://www.bad.org.uk/shared/get-file.ashx?id=227&itemtype=document\" data-hyperlink-id=\"692174c6-f0bb-403a-bc75-abad0096151b\">British Association of Dermatologists</a>.</li><li><strong>Prescribe symptomatic treatment where necessary.</strong><ul><li>Emollients can be used liberally to soothe the skin. See the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/emollients/\">Emollients</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> for further information.</li><li>Moderately potent topical corticosteroids can be used to reduce inflammation. See the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/topical-corticosteroids/\">Topical corticosteroids</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> for further information.</li><li>Offer a sedating antihistamine (such as chlorphenamine or promethazine) if itch is causing sleeping difficulties (off-label indication).</li></ul></li><li><strong>If the rash does not respond to treatment with topical corticosteroids, or is severe and generalized, </strong>refer to a dermatologist. A short course of oral corticosteroids may be indicated.</li></ul><!-- end field fe9d5b69-538a-49a8-af37-0d1ce4b37a4b --><!-- end item 0c96b684-5b8b-4d2a-9596-4007922d6f0b -->","subChapters":[{"id":"4d996ff8-9ad8-5a95-838f-a6a7d0a0384a","slug":"basis-for-recommendation-845","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0a678023-46ac-4737-a81b-f4cf14ebd877 --><h4>Basis for recommendation</h4><!-- end field 0a678023-46ac-4737-a81b-f4cf14ebd877 -->","summary":null,"htmlStringContent":"<!-- begin item 84590d27-21e3-4c75-9bf5-0045ccbc0bef --><!-- begin field 0b60c4e0-5b9b-454d-98e9-9b85532b2a77 --><h5>Natural history</h5><ul><li>The information about the natural history of polymorphic eruption of pregnancy is derived from expert opinion in narrative review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Taylor, 2016</a>].</li></ul><h5>Symptomatic treatment</h5><ul><li>The recommendations on the use of emollients, topical corticosteroids, and oral antihistamines in the management of polymorphic eruption of pregnancy are based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Lehrhoff, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Taylor, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">PCDS, 2018</a>].<ul><li>Sedating antihistamines may be beneficial owing to their sedative effects rather than specific antihistamine properties [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Summey, 2005</a>].</li><li>The UK Teratology Information Service (UKTIS) states that the sedating antihistamines for which there are most pregnancy safety data are chlorphenamine and promethazine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2019b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2020a</a>]. </li></ul></li><li>The recommendation to refer to secondary care, women with severe, generalized polymorphic eruption of pregnancy that has not responded to topical corticosteroids, is pragmatic based on what CKS considers to be good medical practice. Expert opinion in narrative reviews states that treatment with oral corticosteroids may be indicated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Petropoulou, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Paunescu, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Taylor, 2016</a>].</li></ul><!-- end field 0b60c4e0-5b9b-454d-98e9-9b85532b2a77 --><!-- end item 84590d27-21e3-4c75-9bf5-0045ccbc0bef -->","subChapters":[]}]},{"id":"c76e2786-6cc6-57d6-a9e8-6439f3ba82e3","slug":"atopic-eruption-of-pregnancy","fullItemName":"Atopic eruption of pregnancy","depth":3,"htmlHeader":"<!-- begin field 9180eca8-da4e-4ab1-a4a7-905539180e15 --><h3>How should I manage suspected atopic eruption of pregnancy?</h3><!-- end field 9180eca8-da4e-4ab1-a4a7-905539180e15 -->","summary":null,"htmlStringContent":"<!-- begin item 3f31ee71-be4f-4789-be46-43fef3beddff --><!-- begin field d02e0c1b-7d74-4279-9e7b-97bd0e537df0 --><ul><li><strong>Reassure the woman that atopic eruption of pregnancy responds well to treatment, and there is no serious risk to her or her baby.</strong><ul><li>However, advise that recurrence in future pregnancies is common, and that because atopy can be inherited, the infant may be at increased risk of future atopy.</li></ul></li><li><strong>Provide <a class=\"topic-reference internal-reference\" href=\"/topics/itch-in-pregnancy/management/itch-with-rash/#self-care-advice\">self-care advice</a></strong> to relieve itching.</li><li><strong>Prescribe symptomatic treatment where necessary.</strong><ul><li>Emollients can be used liberally to soothe the skin. See the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/emollients/\">Emollients</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> for further information.</li><li>Moderately potent topical corticosteroids can be used to reduce inflammation. See the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/topical-corticosteroids/\">Topical corticosteroids</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> for further information.</li><li>Offer a sedating antihistamine (such as chlorphenamine or promethazine) if itch is causing sleeping difficulties (off-label indication).</li></ul></li><li><strong>If the rash is particularly severe or unresponsive to treatment in primary care, </strong>refer the woman to a dermatologist. A short course of oral corticosteroids or phototherapy may be indicated.</li></ul><!-- end field d02e0c1b-7d74-4279-9e7b-97bd0e537df0 --><!-- end item 3f31ee71-be4f-4789-be46-43fef3beddff -->","subChapters":[{"id":"d629c923-0eea-573f-87a7-f988b7e91bd9","slug":"basis-for-recommendation-72c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 830f753f-f83e-4a41-8991-580c6f74e300 --><h4>Basis for recommendation</h4><!-- end field 830f753f-f83e-4a41-8991-580c6f74e300 -->","summary":null,"htmlStringContent":"<!-- begin item 72c1a205-e4f3-4344-8480-968b684718ac --><!-- begin field 3d682092-38ae-44f8-a944-c4a11ea1f29e --><h5>Natural history</h5><ul><li>The information about the natural history of atopic eruption of pregnancy is derived from expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Lehrhoff, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Roth, 2016</a>].</li></ul><h5>Symptomatic treatment</h5><ul><li>The recommendations on the use of emollients, topical corticosteroids, and oral antihistamines in the management of atopic eruption of pregnancy are based on expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Lehrhoff, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Roth, 2016</a>].</li><li>The UK Teratology Information Service (UKTIS) states that the sedating antihistamines for which there are most pregnancy safety data are chlorphenamine and promethazine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2019b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">UKTIS, 2020a</a>]. </li></ul><h5>Referral to a dermatologist</h5><ul><li>The recommendation to refer women with severe, refractory atopic eruption of pregnancy to secondary care is pragmatic based on what CKS considers to be good medical practice. Expert opinion in narrative reviews states that treatment with oral corticosteroids and phototherapy may be required [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Roth, 2016</a>].</li></ul><!-- end field 3d682092-38ae-44f8-a944-c4a11ea1f29e --><!-- end item 72c1a205-e4f3-4344-8480-968b684718ac -->","subChapters":[]}]},{"id":"ab654626-9b5d-5b77-95fc-cfa984bb97bb","slug":"pemphigoid-gestationis","fullItemName":"Pemphigoid gestationis","depth":3,"htmlHeader":"<!-- begin field e620a9c2-8cf8-4e62-ab73-e793e3bdfca7 --><h3>How should I manage suspected pemphigoid gestationis?</h3><!-- end field e620a9c2-8cf8-4e62-ab73-e793e3bdfca7 -->","summary":null,"htmlStringContent":"<!-- begin item d6bbcb04-ac60-4e13-b7b1-59d6b963f808 --><!-- begin field e2800ea1-de0f-49fd-b490-f6ade23226fe --><ul><li><strong>Reassure the woman that the prognosis is good with treatment, </strong>but that the condition is likely to have exacerbations and remissions throughout the pregnancy (and will probably flare up at childbirth). There is also about a 10% chance of mild and transient skin lesions in the newborn baby.</li><li><strong>Offer information and advice about pemphigoid gestationis.</strong> A patient information leaflet is available from the <a href=\"https://www.bad.org.uk/shared/get-file.ashx?id=224&itemtype=document\" data-hyperlink-id=\"8f6d4826-eed6-4dde-8dc3-abad00968c0b\">British Association of Dermatologists</a>.</li><li><strong>Refer the woman urgently to dermatology and also refer to obstetrics:</strong><ul><li>Treatment with topical corticosteroids and antihistamines will be required in mild cases.</li><li>Moderate and severe cases are treated by specialists with systemic corticosteroids. </li><li>Additional antenatal surveillance may be advised owing to an increased risk of preterm birth and reduced fetal growth.</li></ul></li></ul><!-- end field e2800ea1-de0f-49fd-b490-f6ade23226fe --><!-- end item d6bbcb04-ac60-4e13-b7b1-59d6b963f808 -->","subChapters":[{"id":"3c4cebe8-1a97-52b4-bb4c-189b1a55c7fd","slug":"basis-for-recommendation-2cd","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d14f3938-b5f9-4e9b-bb9f-ecbe03bcf1f6 --><h4>Basis for recommendation</h4><!-- end field d14f3938-b5f9-4e9b-bb9f-ecbe03bcf1f6 -->","summary":null,"htmlStringContent":"<!-- begin item 2cd40eaa-3aa8-48f5-b92c-16a50ceb4f38 --><!-- begin field dc319b7d-12ad-454e-97ba-e8f0da5356c4 --><h5>Natural history</h5><ul><li>The information about the natural history of pemphigoid gestationis is derived from expert opinion in narrative reviews [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Lehrhoff, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">PCDS, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Sadik, 2016</a>].</li></ul><h5>Referral to obstetrics and dermatology</h5><ul><li>The recommendation to urgently refer women with pemphigoid gestationis to a dermatologist is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">PCDS, 2015</a>] and the recommendation to refer to obstetrics is pragmatic, based on what CKS considers to be good clinical practice:<ul><li>This is a rare condition and so experience in primary care is likely to be limited.</li><li>Owing to the associated increased risk of preterm birth and low birth weight, additional fetal and maternal monitoring may be required [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Bergman, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Lehrhoff, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Vaughan Jones, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">PCDS, 2015</a>].</li><li>Dermatology referral allows for confirmation of the diagnosis, which may only become clear when the bullous stage becomes apparent [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Paunescu, 2008</a>], and administration of systemic corticosteroids where necessary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">PCDS, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Sadik, 2016</a>].</li></ul></li></ul><!-- end field dc319b7d-12ad-454e-97ba-e8f0da5356c4 --><!-- end item 2cd40eaa-3aa8-48f5-b92c-16a50ceb4f38 -->","subChapters":[]}]},{"id":"e18b6378-3b99-572f-bdf5-8ef9be9cb77e","slug":"self-care-advice","fullItemName":"Self-care advice","depth":3,"htmlHeader":"<!-- begin field 65ef0a9d-29bd-40f2-8a25-3ce7e8c9038b --><h3>What self-care advice should I offer?</h3><!-- end field 65ef0a9d-29bd-40f2-8a25-3ce7e8c9038b -->","summary":null,"htmlStringContent":"<!-- begin item fc53c79e-3357-4a90-9c61-b6df5549d52c --><!-- begin field ed8cf507-7881-4bcb-8431-3c8e8c595581 --><ul><li><strong>Advise the woman about self-care measures to reduce itch.</strong></li><li>When bathing, she should:<ul><li>Reduce the amount of time spent in the bath to less than 20 minutes.</li><li>Bathe less frequently, if possible, as washing dries the skin. The axillae, genital area, and under the breasts can be washed daily, but other skin areas can be washed 2–3 times weekly.</li><li>Use cool or lukewarm water (hot water can be drying).</li><li>Avoid bubble bath, soap, and perfumed products. Mild, alcohol-free cleansers should be used, or an emollient used as a soap substitute.</li><li>Avoid vigorously drying the skin, and pat it dry instead.</li></ul></li><li>A cool shower may offer immediate short-term relief from itch, but excessive showering should be avoided as this may dry the skin.</li><li>Nails should be kept short to minimize any skin damage from scratching. Rubbing rather than scratching is advised if the urge to relieve the itch cannot be ignored.</li><li>The indoor environment should be kept cool (particularly the bedroom); humidifying the air may help, particularly during cold winter months.</li><li>Clothing that does not irritate the skin (for example cotton or silk) should be worn, avoiding wool or synthetic fabrics.</li><li>Spicy foods, alcohol, and caffeine should be avoided as they may cause vasodilation, which can worsen itch.</li></ul><!-- end field ed8cf507-7881-4bcb-8431-3c8e8c595581 --><!-- end item fc53c79e-3357-4a90-9c61-b6df5549d52c -->","subChapters":[{"id":"b56d20fd-c8a2-5ef1-9bca-a0e9af070464","slug":"basis-for-recommendation-052","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5c34d7ab-aac4-4ae9-8b5d-558174fa86ac --><h4>Basis for recommendation</h4><!-- end field 5c34d7ab-aac4-4ae9-8b5d-558174fa86ac -->","summary":null,"htmlStringContent":"<!-- begin item 052f3485-af22-481c-9d09-d210bcc9ca7d --><!-- begin field d6ade65f-021b-40d6-ab39-335d06bbf8d4 --><p>Recommendations for self-care are based on expert opinion in a number of narrative reviews, which apply to all types of generalized itch, and are not specific to pregnancy-related dermatoses [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Moses, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Greaves, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Yosipovitch, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Roebuck, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Davies, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-in-pregnancy/references/\">Misery, 2007</a>].</p><!-- end field d6ade65f-021b-40d6-ab39-335d06bbf8d4 --><!-- end item 052f3485-af22-481c-9d09-d210bcc9ca7d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}